Underscoring its importance during medulloblastoma progression, mutations in the Shh signaling pathway, including Ptch, Smo and the downstream gene Suppressor of fused (Sufu) have been found in approximately 25–30% of medulloblastoma cases [6]. The gene discussed is SUFU; the disease is medulloblastoma.